Is Ginkgo Bioworks Stock a Good Buy?
Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…
Sell
50
PRCT Quote, Financials, Valuation and Earnings
Last price:
$59.30
Seasonality move
:
9.14%
Day range:
$57.21 - $59.06
52-week range:
$47.04 - $103.81
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
12.38x
P/B ratio:
8.26x
Volume:
1.5M
Avg. volume:
1.1M
1-year change:
-14.78%
Market cap:
$3.2B
Revenue:
$224.5M
EPS (TTM):
-$1.70
Earnings Data
Next earnings date for PRCT
Aug 01
2025
Most recent earnings per share
-$0.45
Beat by $0.04
(Apr 24/2025)
Consensus Estimate
-$0.49
(Apr 24/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
PRCT Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 08/01/2025 | Q2 | $75.7M | -- | -- | -$0.40 | -- |
| 04/24/2025 | Q1 | $65.4M | $69.2M | -$0.45 | -$0.49 | $0.04 |
| 02/25/2025 | Q4 | $66.8M | $68.2M | -$0.35 | -$0.35 | -$0.00 |
| 10/28/2024 | Q3 | $53.2M | $58.4M | -$0.40 | -$0.49 | $0.09 |
| 08/01/2024 | Q2 | $50.2M | $53.4M | -$0.50 | -$0.52 | $0.02 |
| 05/01/2024 | Q1 | $41.7M | $44.5M | -$0.51 | -$0.57 | $0.05 |
| 02/27/2024 | Q4 | $41.9M | $43.6M | -$0.54 | -$0.45 | -$0.09 |
| 11/01/2023 | Q3 | $33.8M | $35.1M | -$0.51 | -$0.52 | $0.01 |
| 07/27/2023 | Q2 | $30.5M | $33.1M | -$0.56 | -$0.56 | $0.00 |
| 04/27/2023 | Q1 | $24.3M | $24.4M | -$0.63 | -$0.59 | -$0.04 |
| 02/28/2023 | Q4 | -- | $23.8M | -$0.63 | -- | -- |
| 11/03/2022 | Q3 | -- | $20.3M | -$0.51 | -- | -- |
| 08/04/2022 | Q2 | -- | $16.7M | -$0.43 | -- | -- |
| 05/05/2022 | Q1 | -- | $14.2M | -$0.39 | -- | -- |
| 03/08/2022 | Q4 | -- | $10.1M | -$0.42 | -- | -- |
| 11/05/2021 | Q3 | -- | $8.7M | -$1.22 | -- | -- |
| 06/30/2021 | Q2 | -- | $8.5M | -$0.35 | -- | -- |
| 03/31/2021 | Q1 | -- | $7.2M | -$0.36 | -- | -- |
| 12/31/2020 | Q4 | -- | $3.2M | -$0.43 | -- | -- |
| 09/30/2020 | Q3 | -- | $2.1M | -$0.34 | -- | -- |
PROCEPT BioRobotics Earnings Questions
-
How Much did PROCEPT BioRobotics Generate in Revenue Last Quarter?
PROCEPT BioRobotics reported $69.2M worth of top line sales in its most recent quarter.
-
Did PROCEPT BioRobotics Beat Earnings Last Quarter?
PROCEPT BioRobotics announced earnings per share of -$0.45 which represents a beat of analyst forecast a -$0.49 per share.
-
Is PROCEPT BioRobotics Profitable?
PROCEPT BioRobotics reported $44.2M that represents $0.80 per share over the last quarter.
-
What is the Analyst Consensus for PROCEPT BioRobotics EPS Next Year?
PROCEPT BioRobotics's earnings are forecast to decrease from -$1.75 per share to -$1.75 per share next year representing a decrease of -14.37%.
-
When is PROCEPT BioRobotics's Earnings Date?
PROCEPT BioRobotics's next earnings date is August 1, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Mobileye Might Be Wall Street’s Next Big Surprise
The trend to automate vehicles started long ago when adding…
Why Is Rigetti Stock Going Up?
Quantum computing firm Rigetti Computing (NASDAQ:RGTI) has been one of…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 38x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
81
SMLR alert for May 19
Semler Scientific [SMLR] is up 5.85% over the past day.
Sell
25
GLOB alert for May 19
Globant SA [GLOB] is up 4.02% over the past day.
Buy
94
HIMS alert for May 19
Hims & Hers Health [HIMS] is down 3.57% over the past day.
